|
|
|
Volumn 1, Issue 6, 1995, Pages 38-
|
|
Merck announces compassionate-treatment lottery for Crixivan.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
INDINAVIR;
PROTEINASE INHIBITOR;
PYRIDINE DERIVATIVE;
ARTICLE;
CD4 LYMPHOCYTE COUNT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PATIENT SELECTION;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
UNITED STATES;
CD4 LYMPHOCYTE COUNT;
CLINICAL TRIALS, PHASE III;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
INDINAVIR;
PATIENT SELECTION;
PYRIDINES;
RANDOMIZED CONTROLLED TRIALS;
UNITED STATES;
|
|
EID: 0029335287
PISSN: 1081454X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|